局部晚期非小细胞肺癌的同期放化疗进展-协和王绿化.pptVIP

Received Mar 8, 2012, and in revised form Apr 19, 2012. Accepted for publication Apr 29, 2012 Conclusion Patients undergoing CCRT for NSCLC, pneumonitis risk is associated with the type of chemotherapy regimen, dosimetric parameters, and patient age. Fatal pneumonitis is uncommon but is associated with large doses per fraction, large V20, and lower-lobe tumors. Further research is needed to evaluate methods to mitigate pneumonitis risk in patients undergoing curative-intent CCRT. Poor Baseline Pulmonary Function May Not Increase the Risk of Radiation Induced Lung Toxicity Jingbo Wang, M.D.; Ji